glutathione synthetase deficiency schizophrenia Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment Altered serum glutathione disulfide levels
Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy BMC Psychiatry Springer Nature Link Schizophrenia and Glutathione: A Challenging Story From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment Neuropsychopharmacology Glutathione Participation in the Prevention of Cardiovascular Diseases Frontiers Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development ScienceDirect
Pay in 4 interest-free payments of $6.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





